Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Immunovant Inc stock

Learn how to easily invest in Immunovant Inc stock.

Immunovant Inc is a biotechnology business based in the US. Immunovant Inc shares (IMVT) are listed on the NASDAQ and all prices are listed in US Dollars. Immunovant Inc employs 124 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Immunovant Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IMVT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Immunovant Inc stock price (NASDAQ: IMVT)

Use our graph to track the performance of IMVT stocks over time.

Immunovant Inc shares at a glance

Information last updated 2022-09-19.
Latest market close$4.88
52-week range$3.15 - $9.54
50-day moving average $4.93
200-day moving average $5.45
Wall St. target price$9.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.43

Buy Immunovant Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Immunovant Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Immunovant Inc price performance over time

Historical closes compared with the close of $4.88 from 2022-09-23

1 week (2022-09-19) 0.62%
1 month (2022-08-26) -17.71%
3 months (2022-06-24) 17.03%
6 months (2022-03-23) -13.48%
1 year (2021-09-24) -43.58%
2 years (2020-09-25) -86.30%
3 years (2019-09-26) 10.02
5 years (2017-09-22) N/A

Immunovant Inc financials

Gross profit TTM $0
Return on assets TTM -24.58%
Return on equity TTM -41.55%
Profit margin 0%
Book value $3.75
Market capitalisation $533.9 million

TTM: trailing 12 months

Immunovant Inc share dividends

We're not expecting Immunovant Inc to pay a dividend over the next 12 months.

Immunovant Inc share price volatility

Over the last 12 months, Immunovant Inc's shares have ranged in value from as little as $3.145 up to $9.535. A popular way to gauge a stock's volatility is its "beta".

IMVT.US volatility(beta: 0.87)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immunovant Inc's is 0.8669. This would suggest that Immunovant Inc's shares are less volatile than average (for this exchange).

Immunovant Inc overview

Immunovant, Inc. , a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. .

Frequently asked questions

What percentage of Immunovant Inc is owned by insiders or institutions?
Currently 64.783% of Immunovant Inc shares are held by insiders and 41.466% by institutions.
How many people work for Immunovant Inc?
Latest data suggests 124 work at Immunovant Inc.
When does the fiscal year end for Immunovant Inc?
Immunovant Inc's fiscal year ends in March.
Where is Immunovant Inc based?
Immunovant Inc's address is: 320 West 37th Street, New York, NY, United States, 10018
What is Immunovant Inc's ISIN number?
Immunovant Inc's international securities identification number is: US45258J1025
What is Immunovant Inc's CUSIP number?
Immunovant Inc's Committee on Uniform Securities Identification Procedures number is: 42227C102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site